Vanguard Files Form 8.3 Disclosure for Spire Healthcare Group
The filing is a public opening position and dealing disclosure under Rule 8.3 of the Takeover Code.
Related stories
First Solar Reports Q3 2026 Results, Updates Guidance and Announces $500 Million Buyback
First Solar reported net sales of $1.23 billion, down 23% year over year, and diluted earnings per share of $5.30. The company also updated guidance and announced a $500 million sh
M impact | EQUITY | Oct 29, 2026, 08:21 PM UTC
Credit Acceptance announces third-quarter 2026 results
M impact | EQUITY | Oct 29, 2026, 08:18 PM UTC
DaVita Reports Third-Quarter Revenue of $3.58B
M impact | EQUITY | Oct 29, 2026, 08:12 PM UTC
Hercules Capital Reports Third-Quarter 2026 Financial Results
M impact | EQUITY | Oct 29, 2026, 08:07 PM UTC
Alphatec Holdings Reports Third-Quarter 2026 Financial Results
Alphatec Holdings announced financial results for the quarter ended September 30, 2026.
M impact | EQUITY | Oct 29, 2026, 08:06 PM UTC
Biohaven Reports Third-Quarter 2026 Results and FDA Acceptance of Vyglxia Resubmission
The FDA accepted Biohaven’s resubmitted new drug application for Vyglxia. The body is truncated and provides no financial results details.
M impact | EQUITY | Oct 29, 2026, 08:06 PM UTC